Abstract
Background
The guidelines for performing endoscopy in dyspeptic patients based on clinical parameters alone have shown variable performance, and there is a need for better prediction tools.
Aim
We aimed to prospectively develop and validate a simple clinical-cum-laboratory test-based scoring model to identify dyspeptic patients with high risk of upper gastrointestinal malignancy (UGIM).
Methods
Adult patients with dyspeptic symptoms were prospectively recruited over 5 years. Clinical details including alarm features were recorded, and blood tests for hemoglobin and albumin were done before endoscopy. The presence of UGIM was the primary outcome. Risk factors for UGIM were assessed, and based on the OR of significant factors, a predictive scoring model was constructed. ROC curve was plotted to identify optimal cutoff score. The model was validated using bootstrapping technique.
Results
The study included 2324 patients (41.9 ± 12.8 years; 33.4% females). UGIM was noted in 6.8% patients. The final model had following five positive predictors for UGIM—age > 40 years (OR 3.3, score 1); albumin ≤ 3.5 g% (OR 3.4, score 1); Hb ≤ 11 g% (OR 3.3, score 1); alarm features (OR 5.98, score 2); recent onset of symptoms (OR 8.7, score 3). ROC curve had an impressive AUC of 0.9 (0.88–0.93), and a score of 2 had 92.5% sensitivity in predicting UGIM. Validation by bootstrapping showed zero bias, which further strengthened our model.
Conclusion
This simple clinical-cum-laboratory test-based model performed very well in identifying dyspeptic patients at risk of UGIM. This can serve as a useful decision-making tool for referral for endoscopy.
Similar content being viewed by others
References
Bodger K, Eastwood PG, Manning SI, Daly MJ, Heatley RV. Dyspepsia workload in urban general practice and implications of the British Society of Gastroenterology Dyspepsia guidelines (1996). Aliment Pharmacol Ther. 2000;14:413–420.
Jones R, Lydeard S. Dyspepsia in the community: a follow-up study. Br J Clin Pract. 1992;46:95–97.
Talley NJ, Weaver AL, Tesmer DL, Zinsmeister AR. Lack of discriminant value of dyspepsia subgroups in patients referred for upper endoscopy. Gastroenterology. 1993;105:1378–1386.
Breslin NP, Thomson AB, Bailey RJ, et al. Gastric cancer and other endoscopic diagnoses in patients with benign dyspepsia. Gut. 2000;46:93–97.
Thomson AB, Barkun AN, Armstrong D, et al. The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia: the Canadian Adult Dyspepsia Empiric Treatment-Prompt Endoscopy (CADET-PE) study. Aliment Pharmacol Ther. 2003;17:1481–1491.
Hsu YC, Yang TH, Liou JM, et al. Can clinical features stratify use of endoscopy for dyspeptic patients with high background prevalence of upper gastrointestinal cancer? Dig Liver Dis. 2012;44:218–223.
Gillen D, McColl KE. Does concern about missing malignancy justify endoscopy in uncomplicated dyspepsia in patients aged less than 55? Am J Gastroenterol. 1999;94:75–79.
Talley NJ, Vakil NB, Moayyedi P. American gastroenterological association technical review on the evaluation of dyspepsia. Gastroenterology. 2005;129:1756–1780.
Mason JM, Delaney B, Moayyedi P, Thomas M, Walt R, North of England Dyspepsia Guideline Development Group. Managing dyspepsia without alarm signs in primary care: new national guidance for England and Wales. Aliment Pharmacol Ther. 2005;21:1135–1143.
Adang RP, Ambergen AW, Talmon JL, Hasman A, Vismans JF, Stockbrugger RW. The discriminative value of patient characteristics and dyspeptic symptoms for upper gastrointestinal endoscopic findings: a study on the clinical presentation of 1,147 patients. Digestion. 1996;57:118–134.
Canga C 3rd, Vakil N. Upper GI malignancy, uncomplicated dyspepsia, and the age threshold for early endoscopy. Am J Gastroenterol. 2002;97:600–603.
Kapoor N, Bassi A, Sturgess R, Bodger K. Predictive value of alarm features in a rapid access upper gastrointestinal cancer service. Gut. 2005;54:40–45.
Voutilainen M, Mantynen T, Kunnamo I, Juhola M, Mecklin JP, Farkkila M. Impact of clinical symptoms and referral volume on endoscopy for detecting peptic ulcer and gastric neoplasms. Scand J Gastroenterol. 2003;38:109–113.
Emami MH, Ataie-Khorasgani M, Jafari-Pozve N. Diagnostic value of alarm symptoms for upper GI malignancy in patients referred to GI clinic: a 7 years cross sectional study. J Res Med Sci. 2017;22:76.
Wallace MB, Durkalski VL, Vaughan J, et al. Age and alarm symptoms do not predict endoscopic findings among patients with dyspepsia: a multicentre database study. Gut. 2001;49:29–34.
Bai Y, Li ZS, Zou DW, et al. Alarm features and age for predicting upper gastrointestinal malignancy in Chinese patients with dyspepsia with high background prevalence of Helicobacter pylori infection and upper gastrointestinal malignancy: an endoscopic database review of 102,665 patients from 1996 to 2006. Gut. 2010;59:722–728.
Vakil N, Moayyedi P, Fennerty MB, Talley NJ. Limited value of alarm features in the diagnosis of upper gastrointestinal malignancy: systematic review and meta-analysis. Gastroenterology. 2006;131:390–401. (quiz 659-60).
Madsen LG, Bytzer P. The value of alarm features in identifying organic causes of dyspepsia. Can J Gastroenterol. 2000;14:713–720.
Khademi H, Radmard AR, Malekzadeh F, et al. Diagnostic accuracy of age and alarm symptoms for upper GI malignancy in patients with dyspepsia in a GI clinic: a 7-year cross-sectional study. PLoS ONE. 2012;7:e39173.
Croft RP, Nicholls PG, Steyerberg EW, Richardus JH, Cairns W, Smith S. A clinical prediction rule for nerve-function impairment in leprosy patients. Lancet. 2000;355:1603–1606.
Beyene J, Atenafu EG, Hamid JS, To T, Sung L. Determining relative importance of variables in developing and validating predictive models. BMC Med Res Methodol. 2009;9:64.
Williams B, Luckas M, Ellingham JH, Dain A, Wicks AC. Do young patients with dyspepsia need investigation? Lancet. 1988;2:1349–1351.
Liou JM, Lin JT, Wang HP, et al. The optimal age threshold for screening upper endoscopy for uninvestigated dyspepsia in Taiwan, an area with a higher prevalence of gastric cancer in young adults. Gastrointest Endosc. 2005;61:819–825.
Faintuch JJ, Silva FM, Navarro-Rodriguez T, et al. Endoscopic findings in uninvestigated dyspepsia. BMC Gastroenterol. 2014;14:19.
Chen SL, Gwee KA, Lee JS, et al. Systematic review with meta-analysis: prompt endoscopy as the initial management strategy for uninvestigated dyspepsia in Asia. Aliment Pharmacol Ther. 2015;41:239–252.
Azzam NA, Almadi MA, Alamar HH, et al. Performance of American Society for Gastrointestinal Endoscopy guidelines for dyspepsia in Saudi population: prospective observational study. World J Gastroenterol. 2015;21:637–643.
Lieberman D, Fennerty MB, Morris CD, Holub J, Eisen G, Sonnenberg A. Endoscopic evaluation of patients with dyspepsia: results from the national endoscopic data repository. Gastroenterology. 2004;127:1067–1075.
Astin MP, Martins T, Welton N, Neal RD, Rose PW, Hamilton W. Diagnostic value of symptoms of oesophagogastric cancers in primary care: a systematic review and meta-analysis. Br J Gen Pract. 2015;65:e677–e691.
Lee SW, Chang CS, Yeh HJ, Lien HC, Lee TY, Peng YC. The diagnostic value of alarm features for identifying types and stages of upper gastrointestinal malignancies. Gastroenterol Res. 2017;10:120–125.
Bowrey DJ, Griffin SM, Wayman J, Karat D, Hayes N, Raimes SA. Use of alarm symptoms to select dyspeptics for endoscopy causes patients with curable esophagogastric cancer to be overlooked. Surg Endosc. 2006;20:1725–1728.
Christie J, Shepherd NA, Codling BW, Valori RM. Gastric cancer below the age of 55: implications for screening patients with uncomplicated dyspepsia. Gut. 1997;41:513–517.
Vakil N, Talley N, van Zanten SV, et al. Cost of detecting malignant lesions by endoscopy in 2741 primary care dyspeptic patients without alarm symptoms. Clin Gastroenterol Hepatol. 2009;7:756–761.
Phull PS, Salmon CA, Park KG, Rapson T, Thompson AM, Gilbert FJ. Age threshold for endoscopy and risk of missing upper gastrointestinal malignancy—data from the Scottish audit of gastric and oesophageal cancer. Aliment Pharmacol Ther. 2006;23:229–233.
Sung JJ, Lao WC, Lai MS, et al. Incidence of gastroesophageal malignancy in patients with dyspepsia in Hong Kong: implications for screening strategies. Gastrointest Endosc. 2001;54:454–458.
Sumathi B, Navaneethan U, Jayanthi V. Appropriateness of indications for diagnostic upper gastrointestinal endoscopy in India. Singap Med J. 2008;49:970–976.
Moayyedi PM, Lacy BE, Andrews CN, Enns RA, Howden CW, Vakil N. ACG and CAG clinical guideline: management of dyspepsia. Am J Gastroenterol. 2017;112:988–1013.
Maconi G, Manes G, Porro GB. Role of symptoms in diagnosis and outcome of gastric cancer. World J Gastroenterol. 2008;14:1149–1155.
Sundar N, Muraleedharan V, Pandit J, Green JT, Crimmins R, Swift GL. Does endoscopy diagnose early gastrointestinal cancer in patients with uncomplicated dyspepsia? Postgrad Med J. 2006;82:52–54.
Brewczynski A, Jablonska B, Pawlicki K. Associations between nutritional parameters and clinicopathologic factors in patients with gastric cancer: a comprehensive study. Nutr Cancer. 2017;69:752–761.
Corona LP, de Oliveira Duarte YA, Lebrao ML. Markers of nutritional status and mortality in older adults: the role of anemia and hypoalbuminemia. Geriatr Gerontol Int. 2018;18:177–182.
Funding
The study was funded by an internal Grant (FLUID Grant) from the parent institute (Christian Medical College, Vellore) (Grant No. 22X 453) where the study was done.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that none of them have any potential conflict of interests.
Rights and permissions
About this article
Cite this article
Dutta, A.K., Rebekah, G., Chowdhury, S.D. et al. A Simple Pre-endoscopy Score for Predicting Risk of Malignancy in Patients with Dyspepsia: A 5-Year Prospective Study. Dig Dis Sci 63, 3442–3447 (2018). https://doi.org/10.1007/s10620-018-5245-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-018-5245-7